U.S. Markets close in 5 hrs 11 mins

This Biotech Stock Pops 30% On FDA Nod — 'Slamming Door' On Woes

ALLISON GATLIN
This Biotech Stock Pops 30% On FDA Nod — 'Slamming Door' On Woes

Amag increased its value by nearly a third Thursday after U.S. regulators approved a second drug from the biotech this month.